Every record from Janoshik · page 54
The single largest contributor to the index and the de facto reference against which the other five labs are calibrated here. Measured offset against the reference laboratory is 0.000 pp. Full laboratory profile →
| Report | Compound | Supplier | Lot | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|
| AX-2025-021137 | PT-141 (Bremelanotide) | WXT | WXT-2411-R5246 | 2025-Q1 | 98.26 | 4.72 | 89.8 | Buyer-sourced | 1 | FAIL |
| AX-2025-021035 | Survodutide | WXT | WXT-2501-X3943 | 2025-Q2 | 98.21 | 3.59 | 101.4 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019327 | MK-677 (Ibutamoren mesylate) | TFC | TFC-2505-N7258 | 2025-Q2 | 99.48 | 6.17 | 105.1 | Supplier-supplied | 2 | FAIL |
| AX-2025-019094 | GHRP-6 | JEEP | JEEP-2503-B3455 | 2025-Q2 | 99.87 | 5.40 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-021225 | Hexarelin | BCH | BCH-2501-B6879 | 2025-Q2 | 97.56 | 5.75 | — | Laboratory-retained | 2 | FAIL |
| AX-2025-020659 | L-Glutathione (reduced) | SSA | SSA-2501-W8087 | 2025-Q1 | 98.78 | 10.95 | — | Buyer-sourced | 0 | PASS |
| AX-2025-020753 | IGF-1 LR3 | SGN | SGN-2409-D9887 | 2025-Q1 | 97.23 | 6.39 | — | Supplier-supplied | 0 | PASS |
| AX-2025-021200 | CJC-1295 (no DAC) | BCH | BCH-2502-A6537 | 2025-Q1 | 98.86 | 4.13 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019706 | Tirzepatide | HJ | HJ-2501-P2892 | 2025-Q1 | 97.85 | 2.52 | — | Buyer-sourced | 2 | MARGINAL |
| AX-2025-018555 | TB-500 | WWB | WWB-2501-Y4287 | 2025-Q2 | 99.37 | 3.46 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2025-019849 | AOD-9604 | SWB | SWB-2502-N4413 | 2025-Q1 | 99.01 | 4.29 | — | Supplier-supplied | 0 | PASS |
| AX-2025-019503 | Melanotan II | Homopeptide | HOMO-2502-H1007 | 2025-Q1 | 99.78 | 3.34 | 106.5 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018763 | TB-500 | QSC | QSC-2411-X7470 | 2025-Q1 | 99.87 | 5.52 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019789 | GHRP-2 | HJ | HJ-2412-G3929 | 2025-Q1 | 99.41 | 5.31 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020454 | Liraglutide | KP | KP-2502-E5076 | 2025-Q1 | 98.91 | 6.43 | 92.1 | Supplier-supplied | 0 | PASS |
| AX-2025-020026 | Kisspeptin-10 | ERP | ERP-2504-G6947 | 2025-Q2 | 99.31 | 5.37 | 98.1 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018854 | Liraglutide | QSC | QSC-2502-M9247 | 2025-Q1 | 99.02 | 2.92 | 102.8 | Supplier-supplied | 0 | PASS |
| AX-2025-020528 | Semaglutide | KP | KP-2410-W6441 | 2025-Q1 | 97.21 | 3.75 | 97.6 | Laboratory-retained | 2 | MARGINAL |
| AX-2025-020374 | Retatrutide | MKM | MKM-2504-F3495 | 2025-Q2 | 98.36 | 7.19 | 90.6 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019795 | GHRP-2 | HJ | HJ-2412-G3929 | 2025-Q1 | 99.25 | 5.92 | 98.8 | Supplier-supplied | 2 | FAIL |
| AX-2025-020821 | Semaglutide | SGN | SGN-2410-D9857 | 2025-Q1 | 98.28 | 4.06 | 105.8 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-020282 | Enclomiphene citrate | MKM | MKM-2408-L2880 | 2025-Q1 | 98.03 | 4.35 | 107.4 | Buyer-sourced | 1 | FAIL |
| AX-2025-020062 | Tirzepatide | ERP | ERP-2502-T7984 | 2025-Q1 | 97.77 | 3.50 | 101.5 | Laboratory-retained | 1 | MARGINAL |
| AX-2025-019796 | GHRP-2 | HJ | HJ-2412-G3929 | 2025-Q1 | 99.59 | 5.10 | 96.2 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019707 | Tirzepatide | HJ | HJ-2501-P2892 | 2025-Q1 | 98.44 | 2.25 | 89.7 | Supplier-supplied | 3 | MARGINAL |
| AX-2025-019418 | TB-500 | Homopeptide | HOMO-2410-E8462 | 2025-Q1 | 99.76 | 4.62 | 107.2 | Supplier-supplied | 0 | PASS |
| AX-2025-019221 | Semaglutide | TFC | TFC-2502-L6365 | 2025-Q1 | 98.42 | 3.55 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018810 | Kisspeptin-10 | QSC | QSC-2412-W8004 | 2025-Q1 | 99.76 | 5.21 | 90.7 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018472 | Tirzepatide | WWB | WWB-2502-U2990 | 2025-Q1 | 99.08 | 3.29 | 101.5 | Supplier-supplied | 0 | PASS |
| AX-2025-020815 | Semaglutide | SGN | SGN-2410-D9857 | 2025-Q1 | 97.81 | 5.11 | — | Supplier-supplied | 3 | MARGINAL |
| AX-2025-019774 | TB-500 | HJ | HJ-2501-A3383 | 2025-Q1 | 98.97 | 4.74 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2025-019222 | Semaglutide | TFC | TFC-2502-L6365 | 2025-Q1 | 98.29 | 3.51 | — | Supplier-supplied | 0 | PASS |
| AX-2025-018637 | TB-500 | QYB | QYB-2408-A5127 | 2025-Q1 | 99.37 | 5.01 | — | Supplier-supplied | 3 | FAIL |
| AX-2025-018603 | Ipamorelin | QYB | QYB-2408-A5377 | 2025-Q1 | 99.93 | 4.84 | 96.7 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020142 | Enclomiphene citrate | GGPeps | GGPE-2410-S9487 | 2025-Q1 | 97.93 | 3.82 | — | Supplier-supplied | 1 | FAIL |
| AX-2025-020037 | BPC-157 | ERP | ERP-2502-P7707 | 2025-Q1 | 99.45 | 3.47 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019510 | Humanin (HNG) | Homopeptide | HOMO-2408-A1230 | 2025-Q1 | 99.57 | 5.05 | 105.7 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018720 | Tirzepatide | QSC | QSC-2408-T6517 | 2025-Q1 | 99.93 | 5.98 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019499 | Melanotan II | Homopeptide | HOMO-2502-H1007 | 2025-Q1 | 99.26 | 2.84 | 98.1 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019205 | GHRP-2 | TFC | TFC-2411-A6347 | 2025-Q1 | 99.26 | 2.43 | — | Laboratory-retained | 1 | MARGINAL |